DUPLICATE: DEVELOPMENT AND VALIDATION OF AN ENZYME-LINKED IMMUNOASSAY KIT FOR DIAGNOSIS AND SURVEILLANCE OF COVID-19

2021, 70, 1731 Sabino, 2021, Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence, Lancet, 397, 452, 10.1016/S0140-6736(21)00183-5 Naveca, 2021, COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence, Nat Med, 10.1038/s41591-021-01378-7 Center for Systems Science and Engineering (CSSE) at Johns Hopkins University, Coronavirus COVID-19 Global Cases, (2021). https://coronavirus.jhu.edu/map.html (accessed July 07, 2022). Traugott, 2020, Performance of severe acute respiratory syndrome coronavirus 2 antibody assays in different stages of infection: Comparison of commercial enzyme-linked immunosorbent assays and rapid tests, J. Infect. Dis., 222, 362, 10.1093/infdis/jiaa305 Chan, 2020, Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan, Emerg. Microbes Infect., 9, 221, 10.1080/22221751.2020.1719902 Zhang, 2020, Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1, J. Proteome Res., 19, 1351, 10.1021/acs.jproteome.0c00129 Carattoli, 2005, Recombinant protein-based ELISA and immuno-cytochemical assay for the diagnosis of SARS, J. Med. Virol., 76, 137, 10.1002/jmv.20338 Saijo, 2005, Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS, J. Virol. Methods., 125, 181, 10.1016/j.jviromet.2005.01.028 Woo, 2004, Relative rates of non-pneumonic sars coronavirus infection and SARS coronavirus pneumonia, Infect. Dis. Clin. Pract., 12, 275 Hachim, 2020, Beyond the Spike: identification of viral targets of the antibody response to SARS-CoV-2 in COVID-19 patients, MedRxiv, 2020 Amanat, 2020, A serological assay to detect SARS-CoV-2 seroconversion in humans, Nat. Med., 26, 1033, 10.1038/s41591-020-0913-5 Wajnberg, 2020, 2020 Castillo-Olivares, 2021, Analysis of serological biomarkers of SARS-CoV-2 infection in convalescent samples from severe, moderate and mild COVID-19 cases, Front. Immunol., 12, 4711, 10.3389/fimmu.2021.748291 R. Lassaunière, A. Frische, Z. Harboe, A.C. Nielsen, A. Fomsgaard, K. Krogfelt, C. Jørgensen, Evaluation of nine commercial SARS-CoV-2 immunoassays, (2020) 1–15. https://doi.org/10.1101/2020.04.09.20056325. FDA (U.S. Food and Drug Administration), EUA Authorized Serology Test Performance, (2020). Pastorino, 2020, Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?, Viruses, 12, 10.3390/v12070735 Bland, 1999, Measuring agreement in method comparison studies, Stat. Methods Med. Res., 8, 135, 10.1177/096228029900800204 Rosano, 2014, Recombinant protein expression in Escherichia coli: Advances and challenges, Front. Microbiol., 5, 1, 10.3389/fmicb.2014.00172 Okba, 2020, SARS-CoV-2 specific antibody responses in COVID-19 patients, MedRxiv, 1 Perera, 2020, Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020, Eurosurveillance, 25 Lv, 2020, Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections, Cell Rep, 31, 10.1016/j.celrep.2020.107725 Long, 2020, Antibody responses to SARS-CoV-2 in patients with COVID-19, Nat. Med., 26, 845, 10.1038/s41591-020-0897-1 Touma, 2020, COVID-19: molecular diagnostics overview, J. Mol. Med., 98, 947, 10.1007/s00109-020-01931-w Castro, 2020, COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil, Brazilian J. Infect. Dis., 24, 180, 10.1016/j.bjid.2020.04.003 Zhang, 2020, Evaluation of recombinant nucleocapsid and spike proteins for serological diagnosis of novel coronavirus disease 2019 (COVID-19), MedRxiv, 1 FDA, 2018, 1 Galipeau, 2021, Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2, EBioMedicine, 74, 10.1016/j.ebiom.2021.103700 Anderson, 2021, Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection, Cell, 184, 1858, 10.1016/j.cell.2021.02.010 Ludolf, 2022, Detecting anti-SARS-CoV-2 antibodies in urine samples: A noninvasive and sensitive way to assay COVID-19 immune conversion, Sci Adv, 8, eabn7424, 10.1126/sciadv.abn7424